Amitiza and Tamsulosin hydrochloride drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Amitiza (lubiprostone) and Tamsulosin hydrochloride (tamsulosin hydrochloride). Common drug interactions include eye pain among females and adrenal insufficiency among males.
The phase IV clinical study analyzes what interactions people have when they take Amitiza and Tamsulosin hydrochloride. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.
What is Amitiza?
Amitiza has active ingredients of lubiprostone. It is often used in constipation. eHealthMe is studying from 10,567 Amitiza users. Check the latest studies of Amitiza.
What is Tamsulosin hydrochloride?
Tamsulosin hydrochloride has active ingredients of tamsulosin hydrochloride. It is often used in prostate examination abnormal. eHealthMe is studying from 18,329 Tamsulosin hydrochloride users. Check the latest studies of Tamsulosin hydrochloride.
56 people who take Amitiza and Tamsulosin hydrochloride together, and have interactions are studied.

What are the common drug interactions of Amitiza and Tamsulosin Hydrochloride, by gender? *:
female:
- Eye pain
- Eye pruritus (eye itching)
- Fatigue (feeling of tiredness)
- Feeling hot
- Gamma-glutamyltransferase increased
- Generalised erythema (redness of the skin all over the body)
- Headache (pain in head)
- Hyperhidrosis (abnormally increased sweating)
- Iron deficiency anaemia
- Lacrimation increased
male:
- Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
- Gastrointestinal mucosal necrosis (damage of mucous membrane in gastrointestinal tract)
- Injection site swelling
- Orchitis (inflammation of the testes)
- Platelet count decreased
- Sinusitis (inflammation of sinus)
- Prostate infection
- Drug eruption (adverse drug reaction of the skin)
- Liver disorder (liver diseases)
- Cancer pain
What are the common drug interactions of Amitiza and Tamsulosin Hydrochloride, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Dyspnoea exertional (breathlessness or shortness of breath)
- Eye pain
- Eye pruritus (eye itching)
- Feeling hot
- Generalised erythema (redness of the skin all over the body)
- Lacrimation increased
- Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
- Ocular hyperaemia (an abnormally large amount of blood in eye)
- Oropharyngeal pain
- Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
40-49:
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Asthma
- Blood sodium decreased
- Blood uric acid decreased
- Fatigue (feeling of tiredness)
- Gamma-glutamyltransferase increased
- Rash
50-59:
- Headache (pain in head)
- Weight increased
60+:
- Gastrointestinal mucosal necrosis (damage of mucous membrane in gastrointestinal tract)
- Pneumonia
- Eosinophil count increased
- Haemoglobin decreased
- Malaise (a feeling of general discomfort or uneasiness)
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- White blood cell count decreased
- Decreased appetite
- Depression
- Insomnia (sleeplessness)
What are the existing conditions these people have? *
- High Blood Pressure: 9 people, 16.07%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 16.07%
- Metastases To Bone (cancer spreads to bone): 9 people, 16.07%
- Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 7 people, 12.50%
- Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 7 people, 12.50%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 8.93%
- Diabetes: 5 people, 8.93%
- High Blood Cholesterol: 5 people, 8.93%
- Immunodeficiency Common Variable: 5 people, 8.93%
- Pain: 5 people, 8.93%
* Approximation only. Some reports may have incomplete information.
Do you take Amitiza and Tamsulosin hydrochloride?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Amitiza (10,567 reports)
- Tamsulosin hydrochloride (18,329 reports)
Browse all drug interactions of Amitiza and Tamsulosin hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Amitiza:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Tamsulosin hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Amitiza and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tamsulosin hydrochloride and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on lubiprostone and tamsulosin hydrochloride (the active ingredients of Amitiza and Tamsulosin hydrochloride, respectively), and Amitiza and Tamsulosin hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Zanaflex and Pramine - a second ago
- Could Oxycodone Hydrochloride cause Leukocytosis? - 4 seconds ago
- Could Lyrica cause Catheter Site Pain? - 7 seconds ago
- Drug interactions of Lenvima and Miralax - 12 seconds ago
- Drug interactions of Nizoral and Bisoprolol Fumarate - 14 seconds ago
- Drug interactions of Se and Tepezza - 14 seconds ago
- Could Tea Extract cause Pain? - 15 seconds ago
- Drug interactions of Diltiazem Hydrochloride and Ibrance - 18 seconds ago
- Could Cyclosporine cause Respiratory Tract Infection? - 21 seconds ago
- Drug interactions of Nasacort and Flagyl - 35 seconds ago